The Valens Company Expands Cannabis 2.0 & 3.0
The Valens Company Expands Cannabis 2.0 & 3.0 Footprint with the Acquisition of Leading Canadian Edibles Manufacturer LYF Food Technologies
Read more
BIOTCHNO
Think Research Sees 633 Per Cent Growth in Demand for VirtualCare Telemedicine Platform During COVID-19 Pandemic
Think Research Sees 633 Per Cent Growth in Demand for VirtualCare Telemedicine Platform During COVID-19 Pandemic Canada NewsWire /NOT FOR
Read more
SQI Diagnostics Announces New Corporate Website
Canada NewsWire New Website Provides Essential Information on Company’s Strategic Initiative TORONTO, Feb. 18, 2021/CNW/ – SQI Diagnostics Inc. (the
Read more
Arbitrator Rules for Neptune Wellness Solutions Inc. in Dispute With Azpa Pharmaceuticals Pty. Ltd.
Canada NewsWire LAVAL, QC, Feb. 18, 2021/CNW/ –Neptune Wellness Solutions Inc.(“Neptune” or the “Company”) (NASDAQ: NEPT) (TSX: NEPT), a diversified
Read more
Neptune Wellness Solutions Inc. Announces Termination of “At-The-Market” Offering
Canada NewsWire LAVAL, QC, Feb. 17, 2021/CNW Telbec/ – Neptune Wellness Solutions, Inc. (“Neptune” or the “Company”) (NASDAQ: NEPT) (TSX:
Read more
MindMed’s LSD Neutralizer Study Begins
Canada NewsWire Potential Emergency Off-Switch for Psychedelic Assisted Therapies BASEL, Switzerland,Feb. 17, 2021/CNW/ — MindMed (NEO: MMED), (OTCQB: MMEDF), (DE: MMQ),
Read more
ESSA Pharma Announces Proposed Public Offering of Common Shares
Canada NewsWire VANCOUVER, BC andHOUSTON, Feb. 16, 2021/CNW/ – ESSA Pharma Inc. (“ESSA”, or the “Company”) (Nasdaq: EPIX), a clinical-stage pharmaceutical company
Read more
Medtronic to Announce Financial Results for Its Third Quarter of Fiscal Year 2021
Canada NewsWire DUBLIN, Feb. 16, 2021/CNW/ — Medtronic plc (NYSE:MDT) announced today that it will report financial results for its
Read more
LENVIMA (lenvatinib) Plus KEYTRUDA (pembrolizumab) Demonstrated Superior Progression-Free Survival (PFS) and Overall Survival (OS) Versus Sunitinib as First-Line Treatment for Patients With Advanced Renal Cell Carcinoma
LENVIMA (lenvatinib) Plus KEYTRUDA (pembrolizumab) Demonstrated Superior Progression-Free Survival (PFS) and Overall Survival (OS) Versus Sunitinib as First-Line Treatment for
Read more
Mountain Valley MD Holdings Announces Application for OTCQB Listing in U.S.
Canada NewsWire TORONTO,Jan. 11, 2021/CNW/ –Mountain Valley MD Holdings Inc.(the “Company” or “MVMD“) (CSE: MVMD) (FRA: 20MP) is pleased to
Read more